Joris Wilms insider trades
Open-market stock purchases and sales by Joris Wilms, SVP & CHIEF OPERATING OFFICER at Y-mAbs Therapeutics, Inc, from SEC Form 4 filings since Dec 11, 2018.
Recent trades
No open-market trades in the last 12 months.
Companies traded
- YMAB Y-mAbs Therapeutics, Inc: 1 sale, last Sep 16, 2025